Tags : GRYT Health

PharmaShots Weekly Snapshot (May 11-15, 2020)

Tuba Khan May 18, 2020

1. Janssen to Present Updated Results of JNJ-4528 in P-Ib/II CARTITUDE-1 Study for Multiple Myeloma at ASCO 2020 Published: May 14, 2020 | Tags: Janssen, Update, Results, JNJ-4528, P-Ib/II, CARTITUDE-1, Study, […]readmore

COVID-19 Pharma

GRYT Health and BMS Sign an Agreement to Launch Virtual

Vartika Singh May 12, 2020

Shots: COVID Advocacy Exchange is a virtual platform targeted to unite patient advocacy organizations, patients, policy makers, healthcare practitioners and industry in the exchange of information and will also provide […]readmore

Tags : GRYT Health

PharmaShots Weekly Snapshot (May 11-15, 2020)

GRYT Health and BMS Sign an Agreement to Launch Virtual

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : GRYT Health

PharmaShots Weekly Snapshot (May 11-15, 2020)

GRYT Health and BMS Sign an Agreement to Launch Virtual

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company